Prof Ian Lawrance
St John of God Hospital, WA
Ian Lawrance is a Gastroenterologist and an Adjunct Professor in the School of Medicine and Pharmacology, Faulty of Medicine and Dentistry at the University of Western Australia. He completed his PhD at the John Curtin School of Medical Research in 1998 and undertook a post-doctoral fellowship in the Division of Gastroenterology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
On his return to Australia in 2000, he was appointed as a staff specialist Gastroenterologist at Fremantle Hospital. He was subsequently appointed as a Senior Lecturer and then Associate Professor in the School of Medicine and Pharmacology, UWA. He was a professor from 2009-18 when he became an Adjunct Professor. He has published 120 peer-reviewed papers and numerous book chapters. He is a regular national and international speaker at clinical and research meetings on IBD.
Prof Lawrance was a founding member of the physician-initiated interest group ‘IBD Australia’ in 2002 and was its secretary from 2005-8. A member, and then Joint Chair, of the international IBD genetic Consortium (IIBDGC) and currently sits on the numerous pharmaceutical IBD drug advisory committees (Pharmatel Fresenius Kabi, Janssen-Cilag and Abbott Australasia and Scherring-Plough/Merck, Isopogen).
Prof Lawrance was the head of the department of Gastroenterology and Hepatology at Fremantle Hospital from 2004-7, the director of endoscopic services at Kaleeya Hospital from 2004-7 and was the Director of the Centre for Inflammatory Bowel Diseases (IBD) Fremantle Hospital from its inception to 2015. In 2014 he set up, and continues to run, the Centre for Inflammatory Bowel Disease in the private sector at Saint John of God Hospital, Subiaco.
On his return to Australia in 2000, he was appointed as a staff specialist Gastroenterologist at Fremantle Hospital. He was subsequently appointed as a Senior Lecturer and then Associate Professor in the School of Medicine and Pharmacology, UWA. He was a professor from 2009-18 when he became an Adjunct Professor. He has published 120 peer-reviewed papers and numerous book chapters. He is a regular national and international speaker at clinical and research meetings on IBD.
Prof Lawrance was a founding member of the physician-initiated interest group ‘IBD Australia’ in 2002 and was its secretary from 2005-8. A member, and then Joint Chair, of the international IBD genetic Consortium (IIBDGC) and currently sits on the numerous pharmaceutical IBD drug advisory committees (Pharmatel Fresenius Kabi, Janssen-Cilag and Abbott Australasia and Scherring-Plough/Merck, Isopogen).
Prof Lawrance was the head of the department of Gastroenterology and Hepatology at Fremantle Hospital from 2004-7, the director of endoscopic services at Kaleeya Hospital from 2004-7 and was the Director of the Centre for Inflammatory Bowel Diseases (IBD) Fremantle Hospital from its inception to 2015. In 2014 he set up, and continues to run, the Centre for Inflammatory Bowel Disease in the private sector at Saint John of God Hospital, Subiaco.